{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T10:43:05Z","timestamp":1756809785142},"reference-count":24,"publisher":"National Library of Serbia","issue":"1-2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med pregl","MED PREGLED"],"published-print":{"date-parts":[[2011]]},"abstract":"<jats:p>Introduction. According to the convincing evidence, a decline in mortality\n   rate has been achieved with beta-blockers in patients with an acute\n   myocardial infarction and in post-infarction follow-up. In fact, there has\n   been a clear reduction of sudden coronary death. The necessary condition for\n   the efficiency of beta-blockers is an early use. They are also a medication\n   of choice for angina after an infarction. The objective of this work was to\n   evaluate the use of beta-blockers after a myocardial infarction in various\n   clinical states and to eliminate doubts concerning their prescription. Beta\n   blockers Even in conditions considered contraindications for administration\n   of beta blockers such as old age, diabetes, non-Q-wave myocardial infarction,\n   peripheral vascular disease, arterial disease, heart insufficiency,\n   ventricular arrhythmias, renal disease, chronic obstructive pulmonary\n   disease, asthma and depression, patients benefit from beta blockers when they\n   are given along with a right choice of the medication and a regular follow-up\n   of the patient. Preference is given to cardioselective beta blockers in\n   patients with diabetes or lung disease. Beta-blockers do not cause long-term\n   lipid alterations. Therefore, the matter of clinically significant\n   alterations of lipids or blood glucose levels should not need further\n   consideration as a problem of the treatment of diabetics. Discussion and\n   conclusion. Investigations have proved that the use of beta-blockers reduces\n   the development of cerebrovascular accidents, heart insufficiency and\n   hypertension. Despite strong arguments and numerous recommendations,\n   beta-blockers have not been accepted to a sufficient extent as an integral\n   part of treatment of acute coronary syndrome and related diseases, to the\n   detriment of many lost lives and in spite of favourable pharmaco-economic\n   aspect.<\/jats:p>","DOI":"10.2298\/mpns1102055r","type":"journal-article","created":{"date-parts":[[2011,4,26]],"date-time":"2011-04-26T08:21:03Z","timestamp":1303806063000},"page":"55-60","source":"Crossref","is-referenced-by-count":1,"title":["Use of beta blockers in various clinical states"],"prefix":"10.2298","volume":"64","author":[{"suffix":"V.","given":"Vesna","family":"Radovic","sequence":"first","affiliation":[{"name":"Institut Hemofarm, STADA Hemofarm A.D., Beograd"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1078","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1C472"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1161\/hs0202.102332"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.2298\/MPNS1010662R"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1378\/chest.100.5.1215"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1592\/phco.19.11.974.31575"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.6.3.285"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199308123290702"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09327-3"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01683-7"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199605233342101"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)04440-2"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105033441803"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199808203390801"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13800-7"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(90)90286-A"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(86)80250-9"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011166919718"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.2298\/MPNS0910450R"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199912093412402"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198104023041401"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.11.1326"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(01)00652-0"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1097\/01.TA.0000109859.91202.C8"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(00)00304-1"}],"container-title":["Medicinski pregled","Medical review"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T09:22:35Z","timestamp":1685352155000},"score":1,"resource":{"primary":{"URL":"https:\/\/doiserbia.nb.rs\/Article.aspx?ID=0025-81051102055R"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":24,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.2298\/mpns1102055r","relation":{},"ISSN":["0025-8105","1820-7383"],"issn-type":[{"value":"0025-8105","type":"print"},{"value":"1820-7383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]}}}